APO Research

APO RESEARCH · REPORT

Multi-disease Fundus Imaging-assisted Diagnostic System

Selected research

Industry Growth & Trends

Global Multi-disease Fundus Imaging-assisted Diagnostic System Industry Growth and Trends Forecast to 2032

Market perspective

According to APO Research, the global Multi-disease Fundus Imaging-assisted Diagnostic System market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Multi-disease Fundus Imaging-assisted Diagnostic System is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Multi-disease Fundus Imaging-assisted Diagnostic System is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Multi-disease Fundus Imaging-assisted Diagnostic System is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global companies in the Multi-disease Fundus Imaging-assisted Diagnostic System market include Remidio, RetinAI, RetinaRisk, Eyenuk, Inc., Intelligent Retinal Imaging Systems, Retmarker, CSIRO, WeDoctor Group and VoxelCloud, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Multi-disease Fundus Imaging-assisted Diagnostic System market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Multi-disease Fundus Imaging-assisted Diagnostic System market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Multi-disease Fundus Imaging-assisted Diagnostic System market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Multi-disease Fundus Imaging-assisted Diagnostic System.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading companies in the global Multi-disease Fundus Imaging-assisted Diagnostic System market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Multi-disease Fundus Imaging-assisted Diagnostic System Market by Company

Remidio

RetinAI

RetinaRisk

Eyenuk, Inc.

Intelligent Retinal Imaging Systems

Retmarker

CSIRO

WeDoctor Group

VoxelCloud

Zhenhealth

Tencent Health

Airdoc

Silicon Intelligence

Zhiyuan Huitu

Kangfuzi Health

AEYE Health

RetinaLyze

DeepMind

Multi-disease Fundus Imaging-assisted Diagnostic System Segment by Type

On-premise

Cloud-based

Multi-disease Fundus Imaging-assisted Diagnostic System Segment by Application

Hospitals

Clinics

Multi-disease Fundus Imaging-assisted Diagnostic System Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Multi-disease Fundus Imaging-assisted Diagnostic System market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Multi-disease Fundus Imaging-assisted Diagnostic System and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Multi-disease Fundus Imaging-assisted Diagnostic System.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 5: Detailed analysis of Multi-disease Fundus Imaging-assisted Diagnostic System companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.

Chapter 12: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Global Multi-disease Fundus Imaging-assisted Diagnostic System Market Size (US$ Million) Comparison by Region: 2021 VS 2025 VS 2032 Table 2. Global Multi-disease Fundus Imaging-assisted Diagnostic System Market Size by Region (2021-2026) & (US$ Million) Table 3. Global Multi-disease Fundus Imaging-assisted Diagnostic System Market Share by Region (2021-2026) Table 4. Global Multi-disease Fundus Imaging-assisted Diagnostic System Market Size by Region (2027-2032) & (US$ Million) Table 5. Global Multi-disease Fundus Imaging-assisted Diagnostic System Market Share by Region (2027-2032) Table 6. Global Multi-disease Fundus Imaging-assisted Diagnostic System Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global Multi-disease Fundus Imaging-assisted Diagnostic System Market Size by Type (2021-2026) & (US$ Million) Table 8. Global Multi-disease Fundus Imaging-assisted Diagnostic System Market Size Share by Type (2021-2026) Table 9. Global Multi-disease Fundus Imaging-assisted Diagnostic System Market Size Forecasted by Type (2027-2032) & (US$ Million) Table 10. Global Multi-disease Fundus Imaging-assisted Diagnostic System Market Size Share Forecasted by Type (2027-2032) Table 11. North America Multi-disease Fundus Imaging-assisted Diagnostic System Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 12. North America Multi-disease Fundus Imaging-assisted Diagnostic System Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 13. Europe Multi-disease Fundus Imaging-assisted Diagnostic System Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 14. Europe Multi-disease Fundus Imaging-assisted Diagnostic System Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 15. Asia-Pacific Multi-disease Fundus Imaging-assisted Diagnostic System Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 16. Asia-Pacific Multi-disease Fundus Imaging-assisted Diagnostic System Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 17. Latin America Multi-disease Fundus Imaging-assisted Diagnostic System Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 18. Latin America Multi-disease Fundus Imaging-assisted Diagnostic System Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 19. Middle East and Africa Multi-disease Fundus Imaging-assisted Diagnostic System Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 20. Middle East and Africa Multi-disease Fundus Imaging-assisted Diagnostic System Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 21. Global Multi-disease Fundus Imaging-assisted Diagnostic System Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 22. Global Multi-disease Fundus Imaging-assisted Diagnostic System Market Size by Application (2021-2026) & (US$ Million) Table 23. Global Multi-disease Fundus Imaging-assisted Diagnostic System Market Size Share by Application (2021-2026) Table 24. Global Multi-disease Fundus Imaging-assisted Diagnostic System Market Size Forecasted by Application (2027-2032) & (US$ Million) Table 25. Global Multi-disease Fundus Imaging-assisted Diagnostic System Market Size Share Forecasted by Application (2027-2032) Table 26. North America Multi-disease Fundus Imaging-assisted Diagnostic System Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 27. North America Multi-disease Fundus Imaging-assisted Diagnostic System Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 28. Europe Multi-disease Fundus Imaging-assisted Diagnostic System Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 29. Europe Multi-disease Fundus Imaging-assisted Diagnostic System Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 30. Asia-Pacific Multi-disease Fundus Imaging-assisted Diagnostic System Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 31. Asia-Pacific Multi-disease Fundus Imaging-assisted Diagnostic System Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 32. Latin America Multi-disease Fundus Imaging-assisted Diagnostic System Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 33. Latin America Multi-disease Fundus Imaging-assisted Diagnostic System Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 34. Middle East and Africa Multi-disease Fundus Imaging-assisted Diagnostic System Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 35. Middle East and Africa Multi-disease Fundus Imaging-assisted Diagnostic System Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 36. Multi-disease Fundus Imaging-assisted Diagnostic System Industry Trends Table 37. Multi-disease Fundus Imaging-assisted Diagnostic System Industry Drivers Table 38. Multi-disease Fundus Imaging-assisted Diagnostic System Industry Opportunities and Challenges Table 39. Multi-disease Fundus Imaging-assisted Diagnostic System Industry Restraints Table 40. Global Multi-disease Fundus Imaging-assisted Diagnostic System Revenue by Company (US$ Million) & (2021-2026) Table 41. Global Multi-disease Fundus Imaging-assisted Diagnostic System Revenue Market Share by Company (2021-2026) Table 42. Global Multi-disease Fundus Imaging-assisted Diagnostic System Industry Company Ranking, 2024 VS 2025 VS 2026 Table 43. Global Multi-disease Fundus Imaging-assisted Diagnostic System Key Company Headquarters & Area Served Table 44. Global Multi-disease Fundus Imaging-assisted Diagnostic System Company, Product Type & Application Table 45. Global Multi-disease Fundus Imaging-assisted Diagnostic System Company Commercialization Time Table 46. Global Company Market Concentration Ratio (CR5 and HHI) Table 47. Global Multi-disease Fundus Imaging-assisted Diagnostic System by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 48. Remidio Company Information Table 49. Remidio Business Overview Table 50. Remidio Multi-disease Fundus Imaging-assisted Diagnostic System Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 51. Remidio Multi-disease Fundus Imaging-assisted Diagnostic System Product Portfolio Table 52. Remidio Recent Development Table 53. RetinAI Company Information Table 54. RetinAI Business Overview Table 55. RetinAI Multi-disease Fundus Imaging-assisted Diagnostic System Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 56. RetinAI Multi-disease Fundus Imaging-assisted Diagnostic System Product Portfolio Table 57. RetinAI Recent Development Table 58. RetinaRisk Company Information Table 59. RetinaRisk Business Overview Table 60. RetinaRisk Multi-disease Fundus Imaging-assisted Diagnostic System Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 61. RetinaRisk Multi-disease Fundus Imaging-assisted Diagnostic System Product Portfolio Table 62. RetinaRisk Recent Development Table 63. Eyenuk, Inc. Company Information Table 64. Eyenuk, Inc. Business Overview Table 65. Eyenuk, Inc. Multi-disease Fundus Imaging-assisted Diagnostic System Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 66. Eyenuk, Inc. Multi-disease Fundus Imaging-assisted Diagnostic System Product Portfolio Table 67. Eyenuk, Inc. Recent Development Table 68. Intelligent Retinal Imaging Systems Company Information Table 69. Intelligent Retinal Imaging Systems Business Overview Table 70. Intelligent Retinal Imaging Systems Multi-disease Fundus Imaging-assisted Diagnostic System Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 71. Intelligent Retinal Imaging Systems Multi-disease Fundus Imaging-assisted Diagnostic System Product Portfolio Table 72. Intelligent Retinal Imaging Systems Recent Development Table 73. Retmarker Company Information Table 74. Retmarker Business Overview Table 75. Retmarker Multi-disease Fundus Imaging-assisted Diagnostic System Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 76. Retmarker Multi-disease Fundus Imaging-assisted Diagnostic System Product Portfolio Table 77. Retmarker Recent Development Table 78. CSIRO Company Information Table 79. CSIRO Business Overview Table 80. CSIRO Multi-disease Fundus Imaging-assisted Diagnostic System Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 81. CSIRO Multi-disease Fundus Imaging-assisted Diagnostic System Product Portfolio Table 82. CSIRO Recent Development Table 83. WeDoctor Group Company Information Table 84. WeDoctor Group Business Overview Table 85. WeDoctor Group Multi-disease Fundus Imaging-assisted Diagnostic System Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 86. WeDoctor Group Multi-disease Fundus Imaging-assisted Diagnostic System Product Portfolio Table 87. WeDoctor Group Recent Development Table 88. VoxelCloud Company Information Table 89. VoxelCloud Business Overview Table 90. VoxelCloud Multi-disease Fundus Imaging-assisted Diagnostic System Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 91. VoxelCloud Multi-disease Fundus Imaging-assisted Diagnostic System Product Portfolio Table 92. VoxelCloud Recent Development Table 93. Zhenhealth Company Information Table 94. Zhenhealth Business Overview Table 95. Zhenhealth Multi-disease Fundus Imaging-assisted Diagnostic System Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 96. Zhenhealth Multi-disease Fundus Imaging-assisted Diagnostic System Product Portfolio Table 97. Zhenhealth Recent Development Table 98. Tencent Health Company Information Table 99. Tencent Health Business Overview Table 100. Tencent Health Multi-disease Fundus Imaging-assisted Diagnostic System Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 101. Tencent Health Multi-disease Fundus Imaging-assisted Diagnostic System Product Portfolio Table 102. Tencent Health Recent Development Table 103. Airdoc Company Information Table 104. Airdoc Business Overview Table 105. Airdoc Multi-disease Fundus Imaging-assisted Diagnostic System Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 106. Airdoc Multi-disease Fundus Imaging-assisted Diagnostic System Product Portfolio Table 107. Airdoc Recent Development Table 108. Silicon Intelligence Company Information Table 109. Silicon Intelligence Business Overview Table 110. Silicon Intelligence Multi-disease Fundus Imaging-assisted Diagnostic System Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 111. Silicon Intelligence Multi-disease Fundus Imaging-assisted Diagnostic System Product Portfolio Table 112. Silicon Intelligence Recent Development Table 113. Zhiyuan Huitu Company Information Table 114. Zhiyuan Huitu Business Overview Table 115. Zhiyuan Huitu Multi-disease Fundus Imaging-assisted Diagnostic System Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 116. Zhiyuan Huitu Multi-disease Fundus Imaging-assisted Diagnostic System Product Portfolio Table 117. Zhiyuan Huitu Recent Development Table 118. Kangfuzi Health Company Information Table 119. Kangfuzi Health Business Overview Table 120. Kangfuzi Health Multi-disease Fundus Imaging-assisted Diagnostic System Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 121. Kangfuzi Health Multi-disease Fundus Imaging-assisted Diagnostic System Product Portfolio Table 122. Kangfuzi Health Recent Development Table 123. AEYE Health Company Information Table 124. AEYE Health Business Overview Table 125. AEYE Health Multi-disease Fundus Imaging-assisted Diagnostic System Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 126. AEYE Health Multi-disease Fundus Imaging-assisted Diagnostic System Product Portfolio Table 127. AEYE Health Recent Development Table 128. RetinaLyze Company Information Table 129. RetinaLyze Business Overview Table 130. RetinaLyze Multi-disease Fundus Imaging-assisted Diagnostic System Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 131. RetinaLyze Multi-disease Fundus Imaging-assisted Diagnostic System Product Portfolio Table 132. RetinaLyze Recent Development Table 133. DeepMind Company Information Table 134. DeepMind Business Overview Table 135. DeepMind Multi-disease Fundus Imaging-assisted Diagnostic System Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 136. DeepMind Multi-disease Fundus Imaging-assisted Diagnostic System Product Portfolio Table 137. DeepMind Recent Development Table 138. North America Multi-disease Fundus Imaging-assisted Diagnostic System Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 139. North America Multi-disease Fundus Imaging-assisted Diagnostic System Market Size by Country (2021-2026) & (US$ Million) Table 140. North America Multi-disease Fundus Imaging-assisted Diagnostic System Market Share by Country (2021-2026) Table 141. North America Multi-disease Fundus Imaging-assisted Diagnostic System Market Size Forecast by Country (2027-2032) & (US$ Million) Table 142. North America Multi-disease Fundus Imaging-assisted Diagnostic System Market Share Forecast by Country (2027-2032) Table 143. Europe Multi-disease Fundus Imaging-assisted Diagnostic System Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 144. Europe Multi-disease Fundus Imaging-assisted Diagnostic System Market Size by Country (2021-2026) & (US$ Million) Table 145. Europe Multi-disease Fundus Imaging-assisted Diagnostic System Market Share by Country (2021-2026) Table 146. Europe Multi-disease Fundus Imaging-assisted Diagnostic System Market Size Forecast by Country (2027-2032) & (US$ Million) Table 147. Europe Multi-disease Fundus Imaging-assisted Diagnostic System Market Share Forecast by Country (2027-2032) Table 148. Asia-Pacific Multi-disease Fundus Imaging-assisted Diagnostic System Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 149. Asia-Pacific Multi-disease Fundus Imaging-assisted Diagnostic System Market Size by Country (2021-2026) & (US$ Million) Table 150. Asia-Pacific Multi-disease Fundus Imaging-assisted Diagnostic System Market Share by Country (2021-2026) Table 151. Asia-Pacific Multi-disease Fundus Imaging-assisted Diagnostic System Market Size Forecast by Country (2027-2032) & (US$ Million) Table 152. Asia-Pacific Multi-disease Fundus Imaging-assisted Diagnostic System Market Share Forecast by Country (2027-2032) Table 153. Latin America Multi-disease Fundus Imaging-assisted Diagnostic System Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 154. Latin America Multi-disease Fundus Imaging-assisted Diagnostic System Market Size by Country (2021-2026) & (US$ Million) Table 155. Latin America Multi-disease Fundus Imaging-assisted Diagnostic System Market Share by Country (2021-2026) Table 156. Latin America Multi-disease Fundus Imaging-assisted Diagnostic System Market Size Forecast by Country (2027-2032) & (US$ Million) Table 157. Latin America Multi-disease Fundus Imaging-assisted Diagnostic System Market Share Forecast by Country (2027-2032) Table 158. Middle East & Africa Multi-disease Fundus Imaging-assisted Diagnostic System Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 159. Middle East & Africa Multi-disease Fundus Imaging-assisted Diagnostic System Market Size by Country (2021-2026) & (US$ Million) Table 160. Middle East & Africa Multi-disease Fundus Imaging-assisted Diagnostic System Market Share by Country (2021-2026) Table 161. Middle East & Africa Multi-disease Fundus Imaging-assisted Diagnostic System Market Size Forecast by Country (2027-2032) & (US$ Million) Table 162. Middle East & Africa Multi-disease Fundus Imaging-assisted Diagnostic System Market Share Forecast by Country (2027-2032) Table 163. Research Programs/Design for This Report Table 164. Authors List of This Report Table 165. Secondary Sources List of Figures Figure 1.List of Figures Figure 2. Multi-disease Fundus Imaging-assisted Diagnostic System Product Image Figure 3. Global Multi-disease Fundus Imaging-assisted Diagnostic System Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 4. Global Multi-disease Fundus Imaging-assisted Diagnostic System Market Size (2021-2032) & (US$ Million) Figure 5. Global Multi-disease Fundus Imaging-assisted Diagnostic System Market Share by Region: 2025 VS 2032 Figure 6. Global Multi-disease Fundus Imaging-assisted Diagnostic System Market Share by Region (2021-2032) Figure 7. North America Multi-disease Fundus Imaging-assisted Diagnostic System Market Size Growth Rate (2021-2032) & (US$ Million) Figure 8. Europe Multi-disease Fundus Imaging-assisted Diagnostic System Market Size Growth Rate (2021-2032) & (US$ Million) Figure 9. Asia-Pacific Multi-disease Fundus Imaging-assisted Diagnostic System Market Size Growth Rate (2021-2032) & (US$ Million) Figure 10. Latin America Multi-disease Fundus Imaging-assisted Diagnostic System Market Size Growth Rate (2021-2032) & (US$ Million) Figure 11. Middle East & Africa Multi-disease Fundus Imaging-assisted Diagnostic System Market Size Growth Rate (2021-2032) & (US$ Million) Figure 12. On-premise Image Figure 13. Global On-premise Market Size YoY Growth (2021-2032) & (US$ Million) Figure 14. Cloud-based Image Figure 15. Global Cloud-based Market Size YoY Growth (2021-2032) & (US$ Million) Figure 16. Global Multi-disease Fundus Imaging-assisted Diagnostic System Market Size Overview by Type (2021-2032) & (US$ Million) Figure 17. Global Multi-disease Fundus Imaging-assisted Diagnostic System Market Share by Type 2025 VS 2032 Figure 18. North America Multi-disease Fundus Imaging-assisted Diagnostic System Market Size Share by Type (2021-2032) Figure 19. Europe Multi-disease Fundus Imaging-assisted Diagnostic System Market Size Share by Type (2021-2032) Figure 20. Asia-Pacific Multi-disease Fundus Imaging-assisted Diagnostic System Market Size Share by Type (2021-2032) Figure 21. Latin America Multi-disease Fundus Imaging-assisted Diagnostic System Market Size Share by Type (2021-2032) Figure 22. Middle East and Africa Multi-disease Fundus Imaging-assisted Diagnostic System Market Size Share by Type (2021-2032) Figure 23. Hospitals Image Figure 24. Global Hospitals Market Size YoY Growth (2021-2032) & (US$ Million) Figure 25. Clinics Image Figure 26. Global Clinics Market Size YoY Growth (2021-2032) & (US$ Million) Figure 27. Global Multi-disease Fundus Imaging-assisted Diagnostic System Market Size Overview by Application (2021-2032) & (US$ Million) Figure 28. Global Multi-disease Fundus Imaging-assisted Diagnostic System Market Share by Application 2025 VS 2032 Figure 29. North America Multi-disease Fundus Imaging-assisted Diagnostic System Market Size Share by Application (2021-2032) Figure 30. Europe Multi-disease Fundus Imaging-assisted Diagnostic System Market Size Share by Application (2021-2032) Figure 31. Asia-Pacific Multi-disease Fundus Imaging-assisted Diagnostic System Market Size Share by Application (2021-2032) Figure 32. Latin America Multi-disease Fundus Imaging-assisted Diagnostic System Market Size Share by Application (2021-2032) Figure 33. Middle East and Africa Multi-disease Fundus Imaging-assisted Diagnostic System Market Size Share by Application (2021-2032) Figure 34. Global Top 5 and 10 Multi-disease Fundus Imaging-assisted Diagnostic System Players Market Share by Revenue in 2025 Figure 35. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 36. North America Multi-disease Fundus Imaging-assisted Diagnostic System Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 37. North America Multi-disease Fundus Imaging-assisted Diagnostic System Market Share by Country: 2021 VS 2025 VS 2032 Figure 38. North America Multi-disease Fundus Imaging-assisted Diagnostic System Market Share by Country (2021-2032) Figure 39. Europe Multi-disease Fundus Imaging-assisted Diagnostic System Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 40. Europe Multi-disease Fundus Imaging-assisted Diagnostic System Market Share by Country: 2021 VS 2025 VS 2032 Figure 41. Europe Multi-disease Fundus Imaging-assisted Diagnostic System Market Share by Country (2021-2032) Figure 42. Asia-Pacific Multi-disease Fundus Imaging-assisted Diagnostic System Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 43. Asia-Pacific Multi-disease Fundus Imaging-assisted Diagnostic System Market Share by Country: 2021 VS 2025 VS 2032 Figure 44. Asia-Pacific Multi-disease Fundus Imaging-assisted Diagnostic System Market Share by Country (2021-2032) Figure 45. Latin America Multi-disease Fundus Imaging-assisted Diagnostic System Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. Latin America Multi-disease Fundus Imaging-assisted Diagnostic System Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Latin America Multi-disease Fundus Imaging-assisted Diagnostic System Market Share by Country (2021-2032) Figure 48. Middle East & Africa Multi-disease Fundus Imaging-assisted Diagnostic System Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 49. Middle East & Africa Multi-disease Fundus Imaging-assisted Diagnostic System Market Share by Country: 2021 VS 2025 VS 2032 Figure 50. Middle East & Africa Multi-disease Fundus Imaging-assisted Diagnostic System Market Share by Country (2021-2032) Figure 51. Years Considered Figure 52. Research Process Figure 53. Key Executives Interviewed

Scope & coverage.

Types
  • On-premise
  • Cloud-based
Applications
  • Hospitals
  • Clinics
Companies covered
  • Remidio
  • RetinAI
  • RetinaRisk
  • Eyenuk, Inc.
  • Intelligent Retinal Imaging Systems
  • Retmarker
  • CSIRO
  • WeDoctor Group
  • VoxelCloud
  • Zhenhealth
  • Tencent Health
  • Airdoc
  • Silicon Intelligence
  • Zhiyuan Huitu
  • Kangfuzi Health
  • AEYE Health
  • RetinaLyze
  • DeepMind

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.3 Global Multi-disease Fundus Imaging-assisted Diagnostic System Market Size Overview by Region 2021 VS 2025 VS 2032
  4. 1.4 Global Multi-disease Fundus Imaging-assisted Diagnostic System Market Size by Region (2021-2032)
  5. 1.4.1 Global Multi-disease Fundus Imaging-assisted Diagnostic System Market Size by Region (2021-2026)
  6. 1.4.2 Global Multi-disease Fundus Imaging-assisted Diagnostic System Market Size by Region (2027-2032)
  7. 1.5 Key Regions Multi-disease Fundus Imaging-assisted Diagnostic System Market Size (2021-2032)
  8. 1.5.1 North America Multi-disease Fundus Imaging-assisted Diagnostic System Market Size Growth Rate (2021-2032)
  9. 1.5.2 Europe Multi-disease Fundus Imaging-assisted Diagnostic System Market Size Growth Rate (2021-2032)
  10. 1.5.3 Asia-Pacific Multi-disease Fundus Imaging-assisted Diagnostic System Market Size Growth Rate (2021-2032)
  11. 1.5.4 South America Multi-disease Fundus Imaging-assisted Diagnostic System Market Size Growth Rate (2021-2032)
  12. 1.5.5 Middle East & Africa Multi-disease Fundus Imaging-assisted Diagnostic System Market Size Growth Rate (2021-2032)
2 Multi-disease Fundus Imaging-assisted Diagnostic System Market by Type
  1. 2.1 Type Introduction
  2. 2.1.1 On-premise
  3. 2.1.2 Cloud-based
  4. 2.2 Global Multi-disease Fundus Imaging-assisted Diagnostic System Market Size by Type
  5. 2.2.1 Global Multi-disease Fundus Imaging-assisted Diagnostic System Market Size Overview by Type (2021-2032)
  6. 2.2.2 Global Multi-disease Fundus Imaging-assisted Diagnostic System Historic Market Size Review by Type (2021-2026)
  7. 2.2.3 Global Multi-disease Fundus Imaging-assisted Diagnostic System Market Size Forecasted by Type (2027-2032)
  8. 2.3 Global Multi-disease Fundus Imaging-assisted Diagnostic System Market Size by Regions
  9. 2.3.1 North America Multi-disease Fundus Imaging-assisted Diagnostic System Market Size Breakdown by Type (2021-2026)
  10. 2.3.2 Europe Multi-disease Fundus Imaging-assisted Diagnostic System Market Size Breakdown by Type (2021-2026)
  11. 2.3.3 Asia-Pacific Multi-disease Fundus Imaging-assisted Diagnostic System Market Size Breakdown by Type (2021-2026)
  12. 2.3.4 South America Multi-disease Fundus Imaging-assisted Diagnostic System Market Size Breakdown by Type (2021-2026)
  13. 2.3.5 Middle East and Africa Multi-disease Fundus Imaging-assisted Diagnostic System Market Size Breakdown by Type (2021-2026)
3 Multi-disease Fundus Imaging-assisted Diagnostic System Market by Application
  1. 3.1 Type Introduction
  2. 3.1.1 Hospitals
  3. 3.1.2 Clinics
  4. 3.2 Global Multi-disease Fundus Imaging-assisted Diagnostic System Market Size by Application
  5. 3.2.1 Global Multi-disease Fundus Imaging-assisted Diagnostic System Market Size Overview by Application (2021-2032)
  6. 3.2.2 Global Multi-disease Fundus Imaging-assisted Diagnostic System Historic Market Size Review by Application (2021-2026)
  7. 3.2.3 Global Multi-disease Fundus Imaging-assisted Diagnostic System Market Size Forecasted by Application (2027-2032)
  8. 3.3 Global Multi-disease Fundus Imaging-assisted Diagnostic System Market Size by Regions
  9. 3.3.1 North America Multi-disease Fundus Imaging-assisted Diagnostic System Market Size Breakdown by Application (2021-2026)
  10. 3.3.2 Europe Multi-disease Fundus Imaging-assisted Diagnostic System Market Size Breakdown by Application (2021-2026)
  11. 3.3.3 Asia-Pacific Multi-disease Fundus Imaging-assisted Diagnostic System Market Size Breakdown by Application (2021-2026)
  12. 3.3.4 South America Multi-disease Fundus Imaging-assisted Diagnostic System Market Size Breakdown by Application (2021-2026)
  13. 3.3.5 Middle East and Africa Multi-disease Fundus Imaging-assisted Diagnostic System Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
  1. 4.1 Multi-disease Fundus Imaging-assisted Diagnostic System Industry Trends
  2. 4.2 Multi-disease Fundus Imaging-assisted Diagnostic System Industry Drivers
  3. 4.3 Multi-disease Fundus Imaging-assisted Diagnostic System Industry Opportunities and Challenges
  4. 4.4 Multi-disease Fundus Imaging-assisted Diagnostic System Industry Restraints
5 Competitive Insights by Company
  1. 5.1 Global Top Players by Multi-disease Fundus Imaging-assisted Diagnostic System Revenue (2021-2026)
  2. 5.2 Global Multi-disease Fundus Imaging-assisted Diagnostic System Industry Company Ranking, 2024 VS 2025 VS 2026
  3. 5.3 Global Multi-disease Fundus Imaging-assisted Diagnostic System Key Company Headquarters & Area Served
  4. 5.4 Global Multi-disease Fundus Imaging-assisted Diagnostic System Company, Product Type & Application
  5. 5.5 Global Multi-disease Fundus Imaging-assisted Diagnostic System Company Commercialization Time
  6. 5.6 Market Competitive Analysis
  7. 5.6.1 Global Multi-disease Fundus Imaging-assisted Diagnostic System Market CR5 and HHI
  8. 5.6.2 Global Top 5 and 10 Multi-disease Fundus Imaging-assisted Diagnostic System Players Market Share by Revenue in 2025
  9. 5.6.3 2025 Multi-disease Fundus Imaging-assisted Diagnostic System Tier 1, Tier 2, and Tier 3
6 Company Profiles
  1. 6.1 Remidio
  2. 6.1.1 Remidio Company Information
  3. 6.1.2 Remidio Business Overview
  4. 6.1.3 Remidio Multi-disease Fundus Imaging-assisted Diagnostic System Revenue, Global Share and Gross Margin (2021-2026)
  5. 6.1.4 Remidio Multi-disease Fundus Imaging-assisted Diagnostic System Product Portfolio
  6. 6.1.5 Remidio Recent Developments
  7. 6.2 RetinAI
  8. 6.2.1 RetinAI Company Information
  9. 6.2.2 RetinAI Business Overview
  10. 6.2.3 RetinAI Multi-disease Fundus Imaging-assisted Diagnostic System Revenue, Global Share and Gross Margin (2021-2026)
  11. 6.2.4 RetinAI Multi-disease Fundus Imaging-assisted Diagnostic System Product Portfolio
  12. 6.2.5 RetinAI Recent Developments
  13. 6.3 RetinaRisk
  14. 6.3.1 RetinaRisk Company Information
  15. 6.3.2 RetinaRisk Business Overview
  16. 6.3.3 RetinaRisk Multi-disease Fundus Imaging-assisted Diagnostic System Revenue, Global Share and Gross Margin (2021-2026)
  17. 6.3.4 RetinaRisk Multi-disease Fundus Imaging-assisted Diagnostic System Product Portfolio
  18. 6.3.5 RetinaRisk Recent Developments
  19. 6.4 Eyenuk, Inc.
  20. 6.4.1 Eyenuk, Inc. Company Information
  21. 6.4.2 Eyenuk, Inc. Business Overview
  22. 6.4.3 Eyenuk, Inc. Multi-disease Fundus Imaging-assisted Diagnostic System Revenue, Global Share and Gross Margin (2021-2026)
  23. 6.4.4 Eyenuk, Inc. Multi-disease Fundus Imaging-assisted Diagnostic System Product Portfolio
  24. 6.4.5 Eyenuk, Inc. Recent Developments
  25. 6.5 Intelligent Retinal Imaging Systems
  26. 6.5.1 Intelligent Retinal Imaging Systems Company Information
  27. 6.5.2 Intelligent Retinal Imaging Systems Business Overview
  28. 6.5.3 Intelligent Retinal Imaging Systems Multi-disease Fundus Imaging-assisted Diagnostic System Revenue, Global Share and Gross Margin (2021-2026)
  29. 6.5.4 Intelligent Retinal Imaging Systems Multi-disease Fundus Imaging-assisted Diagnostic System Product Portfolio
  30. 6.5.5 Intelligent Retinal Imaging Systems Recent Developments
  31. 6.6 Retmarker
  32. 6.6.1 Retmarker Company Information
  33. 6.6.2 Retmarker Business Overview
  34. 6.6.3 Retmarker Multi-disease Fundus Imaging-assisted Diagnostic System Revenue, Global Share and Gross Margin (2021-2026)
  35. 6.6.4 Retmarker Multi-disease Fundus Imaging-assisted Diagnostic System Product Portfolio
  36. 6.6.5 Retmarker Recent Developments
  37. 6.7 CSIRO
  38. 6.7.1 CSIRO Company Information
  39. 6.7.2 CSIRO Business Overview
  40. 6.7.3 CSIRO Multi-disease Fundus Imaging-assisted Diagnostic System Revenue, Global Share and Gross Margin (2021-2026)
  41. 6.7.4 CSIRO Multi-disease Fundus Imaging-assisted Diagnostic System Product Portfolio
  42. 6.7.5 CSIRO Recent Developments
  43. 6.8 WeDoctor Group
  44. 6.8.1 WeDoctor Group Company Information
  45. 6.8.2 WeDoctor Group Business Overview
  46. 6.8.3 WeDoctor Group Multi-disease Fundus Imaging-assisted Diagnostic System Revenue, Global Share and Gross Margin (2021-2026)
  47. 6.8.4 WeDoctor Group Multi-disease Fundus Imaging-assisted Diagnostic System Product Portfolio
  48. 6.8.5 WeDoctor Group Recent Developments
  49. 6.9 VoxelCloud
  50. 6.9.1 VoxelCloud Company Information
  51. 6.9.2 VoxelCloud Business Overview
  52. 6.9.3 VoxelCloud Multi-disease Fundus Imaging-assisted Diagnostic System Revenue, Global Share and Gross Margin (2021-2026)
  53. 6.9.4 VoxelCloud Multi-disease Fundus Imaging-assisted Diagnostic System Product Portfolio
  54. 6.9.5 VoxelCloud Recent Developments
  55. 6.10 Zhenhealth
  56. 6.10.1 Zhenhealth Company Information
  57. 6.10.2 Zhenhealth Business Overview
  58. 6.10.3 Zhenhealth Multi-disease Fundus Imaging-assisted Diagnostic System Revenue, Global Share and Gross Margin (2021-2026)
  59. 6.10.4 Zhenhealth Multi-disease Fundus Imaging-assisted Diagnostic System Product Portfolio
  60. 6.10.5 Zhenhealth Recent Developments
  61. 6.11 Tencent Health
  62. 6.11.1 Tencent Health Company Information
  63. 6.11.2 Tencent Health Business Overview
  64. 6.11.3 Tencent Health Multi-disease Fundus Imaging-assisted Diagnostic System Revenue, Global Share and Gross Margin (2021-2026)
  65. 6.11.4 Tencent Health Multi-disease Fundus Imaging-assisted Diagnostic System Product Portfolio
  66. 6.11.5 Tencent Health Recent Developments
  67. 6.12 Airdoc
  68. 6.12.1 Airdoc Company Information
  69. 6.12.2 Airdoc Business Overview
  70. 6.12.3 Airdoc Multi-disease Fundus Imaging-assisted Diagnostic System Revenue, Global Share and Gross Margin (2021-2026)
  71. 6.12.4 Airdoc Multi-disease Fundus Imaging-assisted Diagnostic System Product Portfolio
  72. 6.12.5 Airdoc Recent Developments
  73. 6.13 Silicon Intelligence
  74. 6.13.1 Silicon Intelligence Company Information
  75. 6.13.2 Silicon Intelligence Business Overview
  76. 6.13.3 Silicon Intelligence Multi-disease Fundus Imaging-assisted Diagnostic System Revenue, Global Share and Gross Margin (2021-2026)
  77. 6.13.4 Silicon Intelligence Multi-disease Fundus Imaging-assisted Diagnostic System Product Portfolio
  78. 6.13.5 Silicon Intelligence Recent Developments
  79. 6.14 Zhiyuan Huitu
  80. 6.14.1 Zhiyuan Huitu Company Information
  81. 6.14.2 Zhiyuan Huitu Business Overview
  82. 6.14.3 Zhiyuan Huitu Multi-disease Fundus Imaging-assisted Diagnostic System Revenue, Global Share and Gross Margin (2021-2026)
  83. 6.14.4 Zhiyuan Huitu Multi-disease Fundus Imaging-assisted Diagnostic System Product Portfolio
  84. 6.14.5 Zhiyuan Huitu Recent Developments
  85. 6.15 Kangfuzi Health
  86. 6.15.1 Kangfuzi Health Company Information
  87. 6.15.2 Kangfuzi Health Business Overview
  88. 6.15.3 Kangfuzi Health Multi-disease Fundus Imaging-assisted Diagnostic System Revenue, Global Share and Gross Margin (2021-2026)
  89. 6.15.4 Kangfuzi Health Multi-disease Fundus Imaging-assisted Diagnostic System Product Portfolio
  90. 6.15.5 Kangfuzi Health Recent Developments
  91. 6.16 AEYE Health
  92. 6.16.1 AEYE Health Company Information
  93. 6.16.2 AEYE Health Business Overview
  94. 6.16.3 AEYE Health Multi-disease Fundus Imaging-assisted Diagnostic System Revenue, Global Share and Gross Margin (2021-2026)
  95. 6.16.4 AEYE Health Multi-disease Fundus Imaging-assisted Diagnostic System Product Portfolio
  96. 6.16.5 AEYE Health Recent Developments
  97. 6.17 RetinaLyze
  98. 6.17.1 RetinaLyze Company Information
  99. 6.17.2 RetinaLyze Business Overview
  100. 6.17.3 RetinaLyze Multi-disease Fundus Imaging-assisted Diagnostic System Revenue, Global Share and Gross Margin (2021-2026)
  101. 6.17.4 RetinaLyze Multi-disease Fundus Imaging-assisted Diagnostic System Product Portfolio
  102. 6.17.5 RetinaLyze Recent Developments
  103. 6.18 DeepMind
  104. 6.18.1 DeepMind Company Information
  105. 6.18.2 DeepMind Business Overview
  106. 6.18.3 DeepMind Multi-disease Fundus Imaging-assisted Diagnostic System Revenue, Global Share and Gross Margin (2021-2026)
  107. 6.18.4 DeepMind Multi-disease Fundus Imaging-assisted Diagnostic System Product Portfolio
  108. 6.18.5 DeepMind Recent Developments
7 North America
  1. 7.1 North America Multi-disease Fundus Imaging-assisted Diagnostic System Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 7.2 North America Multi-disease Fundus Imaging-assisted Diagnostic System Market Size by Country (2021-2026)
  3. 7.3 North America Multi-disease Fundus Imaging-assisted Diagnostic System Market Size Forecast by Country (2027-2032)
8 Europe
  1. 8.1 Europe Multi-disease Fundus Imaging-assisted Diagnostic System Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 8.2 Europe Multi-disease Fundus Imaging-assisted Diagnostic System Market Size by Country (2021-2026)
  3. 8.3 Europe Multi-disease Fundus Imaging-assisted Diagnostic System Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
  1. 9.1 Asia-Pacific Multi-disease Fundus Imaging-assisted Diagnostic System Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 9.2 Asia-Pacific Multi-disease Fundus Imaging-assisted Diagnostic System Market Size by Country (2021-2026)
  3. 9.3 Asia-Pacific Multi-disease Fundus Imaging-assisted Diagnostic System Market Size Forecast by Country (2027-2032)
10 South America
  1. 10.1 South America Multi-disease Fundus Imaging-assisted Diagnostic System Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 10.2 South America Multi-disease Fundus Imaging-assisted Diagnostic System Market Size by Country (2021-2026)
  3. 10.3 South America Multi-disease Fundus Imaging-assisted Diagnostic System Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
  1. 11.1 Middle East & Africa Multi-disease Fundus Imaging-assisted Diagnostic System Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 11.2 Middle East & Africa Multi-disease Fundus Imaging-assisted Diagnostic System Market Size by Country (2021-2026)
  3. 11.3 Middle East & Africa Multi-disease Fundus Imaging-assisted Diagnostic System Market Size Forecast by Country (2027-2032)
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research